Investigation of factors related to amyotrophic lateral sclerosis (ALS)
Investigation of the Epidemiological Factors Associated With the Development of Amyotrophic Lateral Sclerosis (ALS)
Hadassah Medical Organization · NCT03366506
This study is trying to understand how different factors like ethnicity, immigration status, and military service might affect people with ALS in Israel.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 12 Years to 120 Years |
| Sex | All |
| Sponsor | Hadassah Medical Organization (other) |
| Locations | 1 site (Jerusalem) |
| Trial ID | NCT03366506 on ClinicalTrials.gov |
What this trial studies
This study investigates the epidemiological factors associated with amyotrophic lateral sclerosis (ALS) in Israel, focusing on differences among ethnic subgroups, immigrant versus native-born populations, and military service profiles. Clinical features will be recorded during routine visits throughout the disease course, allowing for a comprehensive database to correlate these features with potential epidemiological factors. The study aims to gather detailed clinical data, including ALSFRS-R scores and neurological assessments, to better understand the disease's patterns and influences.
Who should consider this trial
Good fit: Ideal candidates include individuals with suspected, possible, probable, or definite ALS.
Not a fit: Patients without a diagnosis of ALS or those who do not meet the inclusion criteria may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of ALS and inform targeted prevention and treatment strategies.
How similar studies have performed: While this study focuses on specific epidemiological factors in ALS, similar observational studies have provided valuable insights into the disease, suggesting potential for meaningful findings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Suspected, possible, probable ,definite ALS Exclusion Criteria: \-
Where this trial is running
Jerusalem
- Hadassah Medical Organisation — Jerusalem, Israel (RECRUITING)
Study contacts
- Principal investigator: Marc Gotkine, MBBS — Hadassah Medical Organization
- Study coordinator: Marc Gotkine, MBBS
- Email: marc@gotkine.com
- Phone: +972507874692
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: ALS